Rob Casper

Rob Casper has extensive experience in clinical operations, serving in various leadership roles, including Vice President, Head of Clinical Operations at Synnovation Therapeutics, and Vice President of Clinical Operations at Adaptive Phage Therapeutics and Altimmune, Inc. Previous positions include Senior Director of Clinical Operations at Kolon TissueGene, Inc. and Symbiomix Therapeutics, LLC. Rob Casper holds two Master of Science degrees in Developmental Psychology and Clinical Counseling and Applied Psychology from The Johns Hopkins University.